Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Transfer technology expert makes multi-million-pound investment
July 18, 2017
By: Tim Wright
Editor-in-Chief, Contract Pharma
Powder containment and aseptic transfer valve specialist ChargePoint Technology is expanding its U.S. presence, following a multi-million-pound investment from LDC. The Liverpool, UK headquartered company struck a deal with the private equity firm in January 2017 to capitalize on the strong demand for its solutions in North America, Europe and Asia. This includes the AseptiSafe and PharmaSafe product ranges, which are used to ensure the safe transfer of active pharmaceutical ingredients (APIs) in small and large-scale pharmaceutical manufacturing environments. This demand has fuelled the need for the expansion of the firm’s support team within North America. A new office, based in San Francisco, CA brings the total number of offices globally to four with other locations including Hong Kong and New Jersey. Chris Rombach, previously of ILC Dover, Pacific Ozone and Stedim Biotech (now part of Sartorius group) joins the team at the San Francisco office as president of ChargePoint Inc. He will be responsible for driving the growth of the entire ChargePoint offering across the U.S., Canada, Mexico and Puerto Rico. This will include the establishment of local sales operations and the creation of new roles in the U.S., as well as new reseller channels. The company has plans to double its global workforce by 2020. “Growing our North American presence is a significant milestone for us and reflects our strategic vision to expand the company in key markets,” said Chris Eccles, chief executive officer, ChargePoint. “Our product range and AfterCare support mean we are ideally placed to meet the increasing demand for safe containment and sterile transfer solutions. The use of split-valve technology is growing in popularity, and can offer an alternative to more cumbersome and costly containment techniques. “Continuing our investment in our business and enhancing the service we can provide our customers at a local level has been our main priority in 2017 so far, and bringing on board new team members with the strategic vision to grow the company globally is key to our goals. We are very pleased to have Chris on board as part of our North America team and have no doubt his industry expertise is a perfect fit for the ChargePoint business.” ChargePoint Technology’s AseptiSafe range provides increased sterility assurance for ingredient and small component transfers in aseptic processing and sterile API production. The PharmaSafe powder containment valves offer the highest level of containment performance to ensure the safe handling of potent APIs, intermediates and pharmaceutical formulations.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !